GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (OTCPK:SHTDF) » Definitions » Valuation Rank

Sinopharm Group Co (Sinopharm Group Co) Valuation Rank


View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sinopharm Group Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co (Sinopharm Group Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (OTCPK:SHTDF) » Definitions » Valuation Rank
Comparable Companies
HKSE:00314 HKSE:02192 HKSE:09955 HKSE:01931 HKSE:02289 HKSE:00673 HKSE:06833 HKSE:00718 HKSE:08372 HKSE:00401 MCK COR CAH HSIC SHSE:601607 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784
Traded in Other Exchanges
SHTDY:USA 01099:Hong Kong X2S:Germany
Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Website
http://www.sinopharmgroup.com.cn
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.